Shin J, Kim J
Biochem Biophys Rep. 2021; 27:101075.
PMID: 34337165
PMC: 8313843.
DOI: 10.1016/j.bbrep.2021.101075.
Mann A, Heseltine G
Can Med Assoc J. 2010; 88(22):1102-7.
PMID: 20327557
PMC: 1921427.
HALLIWELL G, QUINTON R, Williams F
Br J Pharmacol Chemother. 1964; 23:330-50.
PMID: 14228134
PMC: 1704096.
DOI: 10.1111/j.1476-5381.1964.tb01590.x.
IDESTROEM C, CADENIUS B
Psychopharmacologia. 1964; 5:431-9.
PMID: 14194687
DOI: 10.1007/BF02193480.
Alnaes R, Kristiansen J
Arch Psychiatr Nervenkr. 1964; 205:192-203.
PMID: 14172824
DOI: 10.1007/BF00352878.
PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.
DIMASCIO A, HENINGER G, Klerman G
Psychopharmacologia. 1964; 5:361-71.
PMID: 14151549
DOI: 10.1007/BF00441447.
BEHAVIORAL EFFECTS OF INTERACTING IMIPRAMINE AND OTHER DRUGS WITH D-AMPHETAMINE, COCAINE, AND TETRABENAZINE.
SCHECKEL C, Boff E
Psychopharmacologia. 1964; 5:198-208.
PMID: 14138755
DOI: 10.1007/BF00413242.
[ON THE METHODOLOGY OF RESEARCH ON ANTIDEPRESSIVE DRUGS WITH SPECIAL REFERENCE TO IMIPRAMINE (TOFRANIL) AND DESMETHYLIMIPRAMINE (PERTOFRAN)].
HAASE H, Koester H, Koenig M, BLEKER A
Arch Psychiatr Nervenkr. 1963; 204:427-45.
PMID: 14087281
COMPARISON BETWEEN IMIPRAMINE AND DESIPRAMINE IN NORMAL SUBJECTS AND THEIR ACTION IN DEPRESSIVE PATIENTS.
POELDINGER W
Psychopharmacologia. 1963; 4:302-7.
PMID: 14048551
DOI: 10.1007/BF00408186.
Clinical trial with desmethylimipramine (G-35020), a new antidepressive compound.
Ban T, Lehmann H
Can Med Assoc J. 1962; 86:1030-1.
PMID: 13864563
PMC: 1849076.
Antidepressant drugs and ethanol: behavioral and pharmacokinetic interactions in mice.
Cott J, Ogren S
J Neural Transm. 1980; 48(4):223-40.
PMID: 7420073
DOI: 10.1007/BF01250658.
Fluvoxamine and clomipramine in the treatment of cataplexy.
Schachter M, Parkes J
J Neurol Neurosurg Psychiatry. 1980; 43(2):171-4.
PMID: 6766990
PMC: 490494.
DOI: 10.1136/jnnp.43.2.171.
The analysis and disposition of imipramine and its active metabolites in man.
Sutfin T, DeVane C, Jusko W
Psychopharmacology (Berl). 1984; 82(4):310-7.
PMID: 6427820
DOI: 10.1007/BF00427676.
The effect of cocaine and imipramine on tyramine-induced release of noradrenaline-3H from the rat vas deferens in vitro.
Barnett A, Staub M, SYMCHOWICZ S
Br J Pharmacol. 1969; 36(1):79-84.
PMID: 5768130
PMC: 1703582.
DOI: 10.1111/j.1476-5381.1969.tb08305.x.
The effects of drugs inhibiting catecholamine uptake on tyramine and noradrenaline-induced contractions of the isolated rat vas deferens.
Barnett A, SYMCHOWICZ S, TABER R
Br J Pharmacol. 1968; 34(3):484-92.
PMID: 5726781
PMC: 1703532.
DOI: 10.1111/j.1476-5381.1968.tb08476.x.
A study of the interaction between desmethylimipramine and tetrabenazine in normal man.
Dick P, Shepherd M
Psychopharmacologia. 1965; 8(1):32-40.
PMID: 5321986
DOI: 10.1007/BF00405359.
Central antisecretory action of desmethylimipramine in the rat.
RIDLEY P, Mann W
Am J Dig Dis. 1973; 18(6):493-7.
PMID: 4705097
DOI: 10.1007/BF01076600.
Clinical use of psychotherapeutic drugs. II. Antidepressant and antianxiety drugs and special problems in the use of psychotherapeutic drugs.
Hollister L
Drugs. 1972; 4(5):361-410.
PMID: 4569454
DOI: 10.2165/00003495-197204050-00002.
Potentiation of tetrabenazine-induced behavioural depression by imipramine on a discrete-trial avoidance escape schedule.
Szekely J, BORSY J, Ildiko K
Psychopharmacologia. 1974; 38(4):339-43.
PMID: 4427985
DOI: 10.1007/BF00429131.
The effect of amitriptyline on presynaptic mechanisms in noradrenergic nerves.
Hughes I
Br J Pharmacol. 1978; 63(2):315-21.
PMID: 667423
PMC: 1668437.
